Stockhead on MSN
Micro-X moves closer to world-first human imaging as Royal Melbourne Hospital site activates
Micro-X has started activation at its first hospital trial site, the Royal Melbourne Hospital, for its portable Head CT ...
MARS Bioimaging, a New Zealand–headquartered medical device company specialising in portable spectral photon-counting CT scanners for point-of-care diagnosis and clinical research, has closed an ...
Christchurch medtech Mars Bioimaging has raised $15 million in a Series A round to take its portable CT scanner to the market. The Government’s new Golden Visa programme is credited with helping get ...
The global computed tomography (CT) market is expected to register consistent growth, expanding at a compound annual rate of ...
Omni NDE cobots, X-ray end effectors and Voxray’s reconstruction approach enables 5-micron inspection of aerospace parts without size constraints.
Wall Street’s further tech wobble overnight has spooked software, clipped miners, and sent cash hiding in healthcare. "May we ...
At our university, professor Brian Sayre was appointed to lead our campus artificial intelligence (AI) educational and ...
Discover how Electroencephalography (EEG) records brain activity to diagnose epilepsy, strokes, and sleep disorders. Learn ...
Australia is entering a transformative era in healthcare, with advances ranging from dementia-preventing vaccines to ...
Let's see what Bell Potter is saying about this small cap. The post Why this speculative ASX stock could rise 80% appeared first on The Motley Fool Australia.
A busy week of quarterly results delivered regulatory milestones, broker upgrades and mixed share-price moves across ASX healthcare. ... Read More The post Scott Power: Quarterly results build ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results